Magnetic nanoparticle-peptide conjugates for in vitro and in vivo targeting and extraction of cancer cells

Journal of the American Chemical Society

Volumn 130, Issue 31, 2008, Pages 10258-10262

  Scarberry, Kenneth E ^a   Dickerson, Erin B ^a   McDonald, John F ^a   Zhang, Z John ^a  

^a GEORGIA INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINES; COBALT; CYTOLOGY; DIALYSIS; ENZYME INHIBITION; EXTRACTIVE METALLURGY; LIGANDS; MAGNETIC FIELDS; MAGNETIC MATERIALS; NANOPARTICLES; NANOSTRUCTURED MATERIALS; NANOSTRUCTURES; TRANSITION METALS;

ABDOMINAL CAVITY; CANCER CELLS; COBALT SPINEL; FLOW STREAMS; FUNCTIONALIZED; IN-CELL; IN-VITRO; IN-VIVO; MAGNETIC NANO PARTICLES; MALIGNANT CELLS; METASTATIC CANCER CELLS; OVARIAN CANCER CELLS; OVARIAN CANCERS; PEPTIDE CONJUGATES; PERITONEAL CAVITIES; POLYGALACTURONIC ACID; SURVIVAL RATES;

CELLS;

EPHRIN RECEPTOR A2; MAGNETIC COBALT SPINEL FERRITE NANOPARTICLE; NANOPARTICLE; PEPTIDE; POLYGALACTURONIC ACID; TYROSYLSERYLALANYLTYROSYLPROLYLASPARTYLSERYLVALYLPROLYLMETHIONYL METHIONYLSERINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER SURVIVAL; CIRCULATION; DIALYSIS; DRUG BINDING; DRUG CONJUGATION; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA; MAGNETIC FIELD; MOUSE; NONHUMAN; OVARY CANCER; PERITONEAL CAVITY;

ANIMALS; CELL SEPARATION; DRUG DELIVERY SYSTEMS; FEMALE; MAGNETICS; METAL NANOPARTICLES; MICE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; OVARIAN NEOPLASMS; PEPTIDES; RECEPTOR, EPHA2;

EID: 48749085964     PISSN: 00027863     EISSN: None     Source Type: Journal    
DOI: 10.1021/ja801969b     Document Type: Article

References (19)

1. Berry, C. C.; Curtis, A. S. G. J. Phys. D: Appl. Phys. 2003, 36, R198.
2. Ito, A.; Shinkai, M.; Honda, H.; Kobayashi, T. J. Biosci. Bioeng. 2005, 100, 1.
3. Nam, J.-M.; Thaxton, C. S.; Mirkin, C. A. Science 2003, 301, 1884.
4. Georganopoulou, D. G.; Chang, L.; Nam, J.-M.; Thaxton, C. S.; Mufson, E. J.; Klein, W. L.; Mirkin, C. A. Proc. Natl. Acad. Sci. U.S.A. 2005, 102, 2273.
5. Herr, J. K.; Smith, J. E.; Medley, C. D.; Shangguan, D.; Tan, W. Anal. Chem. 2006, 78, 2918.
6. Smith, J. E.; Medley, C. D.; Tang, Z.; Shangguan, D.; Lofton, C.; Tan, W. Anal. Chem. 2007, 79, 3075.
7. Liu, C.; Zou, B.; Rondinone, A. J.; Zhang, Z. J. J. Am. Chem. Soc. 2000, 122, 6263.
8. Song, Q.; Zhang, Z. J. J. Phys. Chem. B 2006, 110, 11205.
9. NIH press release, January 4, 2006; http://www.cancer.gov/newscenter/ pressreleases/IPchemotherapyrelease.
10. Chi, D. S.; Hoskins, W. J. In Ovarian Cancer Methods and Protocols; Bartlett, J. M. S., Ed.; Humana Press: 2000; p 75.
11. Hanahan, D.; Weinberg, R. A. Cell 2000, 100, 57.
12. Fidler, I. J. Nat. Rev. Cancer 2003, 3, 453.
13. Sainz de la Cuesta, R.; Goff, B. A.; Fuller, A. F., Jr.; Nikrui, N.; Eichhorn, J. H.; Rice, L. W. Obstet. Gynecol. 1994, 84, 1.
14. Koolpe, M.; Dail, M.; Pasquale, E. B. J. Biol. Chem. 2002, 277, 46974.
15. Thaker, P. H.; Deavers, M.; Celestino, J.; Thornton, A.; Fletcher, M. S.; Landen, C. N.; Kinch, M. S.; Kiener, P. A.; Sood, A. K. Clin. Cancer Res. 2004, 10, 5145.
16. Han, L.; Dong, Z.; Qiao, Y.; Kristensen, G. B.; Holm, R.; Nesland, J. M.; Z Suo, Z. Gynecol. Oncol. 2005, 99, 278.
17. Clark, K. D.; Volkman, B. F.; Thoetkiattikul, H.; King, D.; Hayakawa, Y.; Strand, M. R. J. Biol. Chem. 2001, 276, 18491.
18. Lacava, L. M.; Garcia, V. A. P.; Kuckelhaus, S.; Azevedo, R. B.; Sadeghiani, N.; Buske, N.; Morais, P. C.; Lacava, Z. G. M. J. Magn. Magn. Mater 2004, 272-276, 2434.
19. Goldstein, D. S.; Lu, M. L.; Hattori, T.; Ratliff, T. L.; Loughlin, K. R.; Kavoussi, L. R. J. Endoruol. 1993, 7, 237.